Alimera Sciences (ALIM)
(Delayed Data from NSDQ)
$5.54 USD
0.00 (0.00%)
Updated Sep 13, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ALIM]
Reports for Purchase
Showing records 61 - 80 ( 98 total )
Industry: Medical - Biomedical and Genetics
UK Real-World Audit Data Demonstrate Improvement in Visual Acuity; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Industry: Medical - Biomedical and Genetics
UK Real-World Audit Data Demonstrate Improvement in Visual Acuity; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Industry: Medical - Biomedical and Genetics
Iluvien for Posterior Uveitis in EMEA In-Licensed From pSivida; Reiterate Buy and Raising Price Target to $5
Provider: Rodman & Renshaw, Co.
Industry: Medical - Biomedical and Genetics
Iluvien for Posterior Uveitis in EMEA In-Licensed From pSivida; Reiterate Buy and Raising Price Target to $5
Provider: H.C. Wainwright & Co., Inc.
Industry: Medical - Biomedical and Genetics
It''s All About Sustained Delivery: ARVO 2017 Key Impressions
Provider: Rodman & Renshaw, Co.
Industry: Medical - Biomedical and Genetics
1Q17 Saw Growth in Revenue and User Demand; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Industry: Medical - Biomedical and Genetics
1Q17 Saw Growth in Revenue and User Demand; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Industry: Medical - Biomedical and Genetics
Real World Iluvien Data Presented at ARVO; 1Q17 Earnings Preview; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Industry: Medical - Biomedical and Genetics
Real World Iluvien Data Presented at ARVO; 1Q17 Earnings Preview; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Industry: Medical - Biomedical and Genetics
A Commercial Steroid Implant for Diabetic Macular Edema- Initiating Coverage With Buy and $4 Price Target.
Provider: Rodman & Renshaw, Co.
Industry: Medical - Biomedical and Genetics
A Commercial Steroid Implant for Diabetic Macular Edema; Initiating Coverage With Buy and $4 Price Target
Provider: H.C. Wainwright & Co., Inc.
Industry: Medical - Biomedical and Genetics
Termination of Coverage
Provider: RODMAN & RENSHAW, CO.
Industry: Medical - Biomedical and Genetics
Glimmers of hope for Iluvien .Waiting for further clarity on the U.S. path (if any)
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Industry: Medical - Biomedical and Genetics
Glimmers of hope for Iluvien .Waiting for further clarity on the U.S. path (if any)
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Industry: Medical - Biomedical and Genetics
DCP announcement positive for Iluvien in Europe...Adopting a wait and see approach
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Industry: Medical - Biomedical and Genetics
DCP announcement positive for Iluvien in Europe...Adopting a wait and see approach
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Industry: Medical - Biomedical and Genetics
Downgrading to Market Perform based on second CRL....
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S